Constellium Cl A saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 79 to 83.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Over 100 years of market history reveals that the market's biggest winners often have an RS Rating north of 80 as they begin their biggest runs.
Constellium Cl A has climbed more than 5% past a 12.40 entry in a first-stage cup without handle, meaning it's now out of a proper buy range. Look for the stock to offer a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Earnings growth dropped in the company's most recent report from 86% to -51%, but the top line rose from 5% to 9%.
The company earns the No. 4 rank among its peers in the Steel-Specialty Alloys industry group. Carpenter Technology is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
